Back
Halozyme Therapeutics, Inc. Stock Price Chart
Stock Forecasting AI Could Help Triple Your Money This Year
Try it now for free.
Buy
65
HALO
Halozyme Therapeutics, Inc.
Last Price:
$69.18
Seasonality Move:
5.49%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Halozyme Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.06 | Buy |
| 20-day SMA: | 65.42 | Buy |
| 50-day SMA: | 67.19 | Buy |
| 200-day SMA: | 63.54 | Buy |
| 8-day EMA: | 67.24 | Buy |
| 20-day EMA: | 66.58 | Buy |
| 50-day EMA: | 67.18 | Buy |
| 200-day EMA: | 63.87 | Buy |
Halozyme Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 58.98 | Buy |
| Chaikin Money Flow: | 516593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.07 - 70.31) | Buy |
| Bollinger Bands (100): | (64.7 - 73.66) | Sell |
Halozyme Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics, Inc. Stock
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 68.87 while HALO 8-day simple moving average is 67.06, which is a Buy signal.
-
The stock price of HALO is 68.87 while Halozyme Therapeutics, Inc. 20-day SMA is 65.42, which makes it a Buy.
-
Halozyme Therapeutics, Inc. 50-day simple moving average is 67.19 while HALO share price is 68.87, making it a Buy technically.
-
HALO stock price is 68.87 and Halozyme Therapeutics, Inc. 200-day simple moving average is 63.54, creating a Buy signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
65
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy or a Sell?
-
Halozyme Therapeutics, Inc. stock is rated a BuyThe current Halozyme Therapeutics, Inc. [HALO] share price is $68.87. The Score for HALO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics, Inc. Stock Info
Market Cap:
8.1B
Price in USD:
68.87
Share Volume:
615K
Halozyme Therapeutics, Inc. 52-Week Range
52-Week High:
79.50
52-Week Low:
47.50
Buy
65
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Halozyme Therapeutics, Inc. Share Price Forecast
-
What is the Halozyme Therapeutics, Inc. stock price today?The Halozyme Therapeutics, Inc. stock price is 68.87 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics, Inc. is not overvalued.
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 68.87 while HALO 8-day exponential moving average is 67.24, which is a Buy signal.
-
The stock price of HALO is 68.87 while Halozyme Therapeutics, Inc. 20-day EMA is 66.58, which makes it a Buy.
-
Halozyme Therapeutics, Inc. 50-day exponential moving average is 67.18 while HALO share price is 68.87, making it a Buy technically.
-
HALO stock price is 68.87 and Halozyme Therapeutics, Inc. 200-day simple moving average is 63.87, creating a Buy signal.
Fundamental Analysis of Halozyme Therapeutics, Inc.
Is Halozyme Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.13 per share, and an increase next year of $1.88 per share.
Technical Analysis of Halozyme Therapeutics, Inc.
Should I short Halozyme Therapeutics, Inc. stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Halozyme Therapeutics, Inc. is a Buy
-
Halozyme Therapeutics, Inc. Relative Strength Index (RSI) is 58.98, which suggest Halozyme Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Halozyme Therapeutics, Inc. is (63.07 - 70.31), which suggest Halozyme Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics, Inc. is (64.7 - 73.66), which suggest Halozyme Therapeutics, Inc. is a Sell
* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.